XNYS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Teladoc posted Q1 2026 revenue of $613.8 million, down 2.5% from $629.4 million a year ago, while swinging from a $0.53 EPS to a -$0.36 loss per share.
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 30,450,903 | $218,680,339 | — | 8/13/2024 |
| Vanguard Group | 21,483,707 | $150,385,949 | — | 1/29/2026 |
| DE Shaw | 140,058,180 | $137,352,661 | — | 2/17/2026 |
| State Street | 25,806,144 | $50,250,929 | — | 2/13/2026 |
| Point72 | 5,699,622 | $39,897,354 | — | 2/17/2026 |
| Citadel Advisors | 2,957,632 | $20,703,424 | — | 2/17/2026 |
| Millennium Management | 1,612,686 | $11,288,802 | — | 2/17/2026 |
| JP Morgan Chase | 937,785 | $6,564,499 | — | 2/11/2026 |
| Fidelity (FMR) | 736,726 | $5,157,083 | — | 2/17/2026 |
| Two Sigma | 677,555 | $4,742,885 | — | 2/17/2026 |
| Bridgewater Associates | 634,479 | $4,441,353 | — | 2/13/2026 |
| AQR Capital | 222,362 | $1,552,086 | — | 2/17/2026 |